NCCN Guidelines for Patients® | Melanoma - page 31

31
NCCN Guidelines for Patients
®
: Melanoma
Version 1.2013
Par t 1
Par t 2
Par t 3
Par t 4
Par t 5
Par t 6
Par t 7
Par t 8
Par t 9
Table 1. Staging of melanoma
ANATOMIC STAGE/PROGNOSTIC GROUPS
Clinical staging*
Pathologic staging**
Stage 0
Tis
N0
M0
Stage 0
Tis
N0
M0
Stage IA T1a
N0
M0
Stage IA T1a
N0
M0
Stage IB T1b
N0
M0
Stage IB T1b
N0
M0
T2a
N0
M0
T2A
N0
M0
Stage IIA T2b
N0
M0
Stage IIA T2b
N0
M0
T3a
N0
M0
T3a
N0
M0
Stage IIB T3b
N0
M0
Stage IIB T3b
N0
M0
T4a
N0
M0
T4a
N0
M0
Stage IIC T4b
N0
M0
Stage IIC T4b
N0
M0
Stage III
Any T
≥N1
M0
Stage IIIA T1–4a
N1a
M0
T1–4a
N2a
M0
Stage IIIB T1–4b
N1a
M0
T1–4b
N2a
M0
T1–4a
N1b
M0
T1–4a
N2b
M0
T1–4a
N2c
M0
Stage IIIC T1–4b
N1b
M0
T1–4b
N2b
M0
T1–4b
N2c
M0
Any T
N3
M0
Stage IV Any T
Any N
M1
Stage IV Any T
Any N
M1
* Clinical staging includes microstaging of the primary melanoma and clinical/radiologic evaluation for metastases. By convention, it should be used after complete excision of the primary melanoma with
clinical assessment for regional and distant metastases.
** Pathologic staging includes microstaging of the primary melanoma and pathologic information about the regional lymph nodes after partial or complete lymphadenectomy. Pathologic Stage 0 or Stage IA
patients are the exception; they do not require pathologic evaluation of their lymph nodes.
Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by
Springer Science+Business Media, LLC,
.
1...,21,22,23,24,25,26,27,28,29,30 32,33,34,35,36,37,38,39,40,41,...108
Powered by FlippingBook